CN114280179B - 艾塞那肽的前处理及其得到的His氨基酸洗脱液中异构体的检测方法 - Google Patents
艾塞那肽的前处理及其得到的His氨基酸洗脱液中异构体的检测方法 Download PDFInfo
- Publication number
- CN114280179B CN114280179B CN202111578449.2A CN202111578449A CN114280179B CN 114280179 B CN114280179 B CN 114280179B CN 202111578449 A CN202111578449 A CN 202111578449A CN 114280179 B CN114280179 B CN 114280179B
- Authority
- CN
- China
- Prior art keywords
- amino acid
- mobile phase
- high performance
- liquid chromatography
- performance liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 57
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 title claims abstract description 39
- 108010011459 Exenatide Proteins 0.000 title claims abstract description 38
- 229960001519 exenatide Drugs 0.000 title claims abstract description 38
- 239000003480 eluent Substances 0.000 title claims abstract description 28
- 238000001514 detection method Methods 0.000 title claims description 18
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 50
- 238000000034 method Methods 0.000 claims abstract description 25
- 238000000926 separation method Methods 0.000 claims abstract description 25
- 238000004458 analytical method Methods 0.000 claims abstract description 24
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims abstract description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 39
- 230000007062 hydrolysis Effects 0.000 claims description 29
- 238000006460 hydrolysis reaction Methods 0.000 claims description 29
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 26
- 239000002904 solvent Substances 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 15
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 241000252233 Cyprinus carpio Species 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 7
- 230000003301 hydrolyzing effect Effects 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 abstract description 12
- 238000002203 pretreatment Methods 0.000 abstract description 8
- 238000002360 preparation method Methods 0.000 abstract 1
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 description 42
- 239000000243 solution Substances 0.000 description 33
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 9
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000012085 test solution Substances 0.000 description 4
- 238000007664 blowing Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 229940100389 Sulfonylurea Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 2
- 229960003105 metformin Drugs 0.000 description 2
- 239000012982 microporous membrane Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Abstract
Description
样品批号 | D-His含量 |
Y200501 | 0.69% |
Y200502 | 0.68% |
Y200503 | 0.70% |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111578449.2A CN114280179B (zh) | 2021-12-22 | 2021-12-22 | 艾塞那肽的前处理及其得到的His氨基酸洗脱液中异构体的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111578449.2A CN114280179B (zh) | 2021-12-22 | 2021-12-22 | 艾塞那肽的前处理及其得到的His氨基酸洗脱液中异构体的检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114280179A CN114280179A (zh) | 2022-04-05 |
CN114280179B true CN114280179B (zh) | 2024-03-15 |
Family
ID=80874275
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111578449.2A Active CN114280179B (zh) | 2021-12-22 | 2021-12-22 | 艾塞那肽的前处理及其得到的His氨基酸洗脱液中异构体的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114280179B (zh) |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6337021B1 (en) * | 1994-12-16 | 2002-01-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Chiral separation of enantiomers by high-speed countercurrent chromatography |
CN101968470A (zh) * | 2010-09-30 | 2011-02-09 | 湖北新生源生物工程股份有限公司 | 一种分离测定乙酰半胱氨酸对映异构体的方法 |
CN104475066A (zh) * | 2014-12-08 | 2015-04-01 | 云南师范大学 | 一种适用于氨基酸手性拆分的高效液相色谱分离柱 |
CN104569238A (zh) * | 2013-10-21 | 2015-04-29 | 中国科学院过程工程研究所 | 一种氨基酸铬螯合物中氨基酸含量的测定方法 |
CN106198816A (zh) * | 2015-05-07 | 2016-12-07 | 华中科技大学 | 一种混合氨基酸含量测定方法 |
CN106290601A (zh) * | 2015-06-29 | 2017-01-04 | 深圳翰宇药业股份有限公司 | 多肽药物中氨基酸消旋和非对映异构体杂质的检测方法 |
CN107515269A (zh) * | 2017-08-15 | 2017-12-26 | 浙江美华鼎昌医药科技有限公司 | 一种艾塞那肽的超高效液相色谱分析方法 |
JP2018100906A (ja) * | 2016-12-20 | 2018-06-28 | 花王株式会社 | キラルアミノ酸の分離方法 |
CN109239242A (zh) * | 2017-07-11 | 2019-01-18 | 齐鲁制药有限公司 | 一种艾塞那肽杂质含量的分析方法 |
CN111505142A (zh) * | 2020-04-26 | 2020-08-07 | 上海市食品药品检验所 | 一种多黏菌素b的氨基酸构型分析方法和n-多肽端序列测序方法 |
CN111693629A (zh) * | 2020-06-25 | 2020-09-22 | 山西振东制药股份有限公司 | 氢溴酸沃替西汀及其有关物质的检测方法和应用 |
CN112500473A (zh) * | 2020-11-18 | 2021-03-16 | 李荣光 | 一种醋酸艾塞那肽的分离纯化方法 |
CN113024392A (zh) * | 2021-02-09 | 2021-06-25 | 上海市食品药品检验研究院 | 一种氘代犬尿氨酸及其在多肽中氨基酸构型分析中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080287650A1 (en) * | 2007-03-01 | 2008-11-20 | Avi Tovi | High purity peptides |
US8614182B2 (en) * | 2009-07-30 | 2013-12-24 | Jiangsu Hansoh Pharmaceuticals Co., Ltd. | GLP-1 analogues and their pharmaceutical salts and uses |
US8945933B2 (en) * | 2009-10-12 | 2015-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Liquid chromatography-mass spectrometry methods for multiplexed detection and quantitation of free amino acids |
TWI477776B (zh) * | 2012-12-18 | 2015-03-21 | 中原大學 | 胜肽之胺基酸序列的測定方法與系統 |
US20160033527A1 (en) * | 2012-12-18 | 2016-02-04 | Chung Yuan Christian University | System and method for determining amino acid sequence of polypeptide |
US20160195502A1 (en) * | 2014-12-31 | 2016-07-07 | Castle Medical, LLC | Method for chiral separation of methamphetamine and amphatamine enantiomers |
CN107531750B (zh) * | 2015-04-28 | 2021-03-16 | 深圳翰宇药业股份有限公司 | 多肽混合物高效液相色谱分析方法 |
US10690635B2 (en) * | 2016-03-23 | 2020-06-23 | Bachem Holding Ag | Purification of glucagon-like peptide 1 analogs |
US11391707B2 (en) * | 2018-07-27 | 2022-07-19 | Waters Technologies Corporation | Liquid chromatography/mass spectrometry methods for the analysis of polar molecules |
-
2021
- 2021-12-22 CN CN202111578449.2A patent/CN114280179B/zh active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6337021B1 (en) * | 1994-12-16 | 2002-01-08 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Chiral separation of enantiomers by high-speed countercurrent chromatography |
CN101968470A (zh) * | 2010-09-30 | 2011-02-09 | 湖北新生源生物工程股份有限公司 | 一种分离测定乙酰半胱氨酸对映异构体的方法 |
CN104569238A (zh) * | 2013-10-21 | 2015-04-29 | 中国科学院过程工程研究所 | 一种氨基酸铬螯合物中氨基酸含量的测定方法 |
CN104475066A (zh) * | 2014-12-08 | 2015-04-01 | 云南师范大学 | 一种适用于氨基酸手性拆分的高效液相色谱分离柱 |
CN106198816A (zh) * | 2015-05-07 | 2016-12-07 | 华中科技大学 | 一种混合氨基酸含量测定方法 |
CN106290601A (zh) * | 2015-06-29 | 2017-01-04 | 深圳翰宇药业股份有限公司 | 多肽药物中氨基酸消旋和非对映异构体杂质的检测方法 |
JP2018100906A (ja) * | 2016-12-20 | 2018-06-28 | 花王株式会社 | キラルアミノ酸の分離方法 |
CN109239242A (zh) * | 2017-07-11 | 2019-01-18 | 齐鲁制药有限公司 | 一种艾塞那肽杂质含量的分析方法 |
CN107515269A (zh) * | 2017-08-15 | 2017-12-26 | 浙江美华鼎昌医药科技有限公司 | 一种艾塞那肽的超高效液相色谱分析方法 |
CN111505142A (zh) * | 2020-04-26 | 2020-08-07 | 上海市食品药品检验所 | 一种多黏菌素b的氨基酸构型分析方法和n-多肽端序列测序方法 |
CN111693629A (zh) * | 2020-06-25 | 2020-09-22 | 山西振东制药股份有限公司 | 氢溴酸沃替西汀及其有关物质的检测方法和应用 |
CN112500473A (zh) * | 2020-11-18 | 2021-03-16 | 李荣光 | 一种醋酸艾塞那肽的分离纯化方法 |
CN113024392A (zh) * | 2021-02-09 | 2021-06-25 | 上海市食品药品检验研究院 | 一种氘代犬尿氨酸及其在多肽中氨基酸构型分析中的应用 |
Non-Patent Citations (3)
Title |
---|
"人血中氨基酸及肉碱定量检测和多肽药物的质量控制";刘洁欣;《中国优秀硕士学位论文全文数据库 (医药卫生科技辑)》;第E079-1页 * |
氨基酸分析方法的研究进展;于泓, 牟世芬;分析化学(第03期);全文 * |
非对映异构体杂质在合成多肽药物中的相关探究;潘俊锋;;广州化工(第12期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN114280179A (zh) | 2022-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103163226A (zh) | 30种氨基酸同时定量检测方法及试剂盒制备 | |
CN107782834B (zh) | 一种针对鱼中生物胺的快速分析方法 | |
CN105403637A (zh) | 一种高通量检测人体血浆中多种氨基酸的质谱方法 | |
CN101726552B (zh) | 一种氨基化合物高效液相色谱柱前衍生化试剂及其检测方法 | |
CN111398450A (zh) | 超高效液相色谱串联质谱技术检测尿液中8种儿茶酚胺及其代谢物的试剂盒 | |
CN114280179B (zh) | 艾塞那肽的前处理及其得到的His氨基酸洗脱液中异构体的检测方法 | |
CN108459119B (zh) | 一种测定极性有机含氮化合物的在线衍生高效液相色谱法 | |
CN111141856B (zh) | 同时检测发酵液中l-高丝氨酸和游离氨基酸的hplc方法 | |
CN113281435B (zh) | 一种测定动物源性饲料原料及饲料中生物胺的检测方法 | |
CN111830185A (zh) | 二氯喹啉酸的超高效液相色谱串联质谱检测方法 | |
CN114813988A (zh) | 一种同时提取和检测头发中甲状腺激素和类固醇激素的方法 | |
CN113495105A (zh) | 一种小牛血清中生物胺的检测方法 | |
CN108037221B (zh) | 用液相色谱法同时分离测定复方氨基酸注射液18aa中蛋氨酸亚砜和蛋氨酸砜杂质的方法 | |
CN112697934A (zh) | 一种复方氨基酸注射液中焦谷氨酸含量的检测方法 | |
CN110702819A (zh) | 一种用高效液相色谱法分离测定含多个手性中心的多肽手性异构体的方法 | |
CN111398494A (zh) | 一种基于反相二维液相色谱的烟碱旋光异构体分离测定方法 | |
CN110618227B (zh) | 一种利用hplc法检测单氰胺溶液中双氰胺含量的方法 | |
CN114924011B (zh) | 高效液相色谱串联质谱法检测血浆中cmpf含量的方法 | |
CN113671064B (zh) | 一种定量分析血浆中氨来占诺的血药浓度的检测方法 | |
CN112433017B (zh) | 一种枸杞亚精胺类特有代谢物的检测方法 | |
CN116858978B (zh) | 一种同时检测门冬胰岛素和德谷胰岛素的方法及其血浆样品处理方法 | |
CN117288869B (zh) | 一种原料药中对甲苯磺酸酯类杂质的检测方法 | |
CN112924566B (zh) | 一种同时检测酶促反应液中甘氨酸和丝氨酸的方法 | |
CN114814005A (zh) | 一种检测血液中齐拉西酮的液相色谱分析方法 | |
CN113189247A (zh) | 一种固态大曲中尿素含量的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20231127 Address after: Room 301, 3rd Floor, Building 1, No. 49 Huatuo Road, Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing, 102629 Applicant after: BEIJING MEDFRON MEDICINA TECHNOLOGY CO.,LTD. Address before: 100000 901, block a, Xincheng culture building, No. 11, Chongwenmenwai, Dongcheng District, Beijing Applicant before: BEIJING MEDFRON MEDICINA TECHNOLOGY CO.,LTD. Applicant before: BEIJING WANPENG LANGGE MEDICINE TECHNOLOGY CO.,LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |